norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet
- RxCUI
- 687424
- RxNorm name
- norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet
- Display name
- norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet
- Full name
- norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 8b247e46-203e-4f5b-b5a7-cbd57341c735 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | f7f7c073-48e0-4065-970b-8103d76b6eb0 | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 6e8bec6f-17ba-4b37-ae6c-07657815f248 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Linyah | NORGESTIMATE AND ETHINYL ESTRADIOL | Northstar Rx LLC | b71a2b34-95bf-4430-83a0-1a4d1218ea3c | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Preferred Pharmaceuticals Inc. | 1f8b9aad-f31f-4cda-861d-c08a977fc923 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 843cbef6-cbfb-4a44-bb80-22930753e4c0 | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 6560d15f-6ce9-4f0e-9b59-043dec35ddd9 | 2024-05-21 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Naari Pte Limited | b936a6fb-27ed-44de-9199-8c656bcd366e | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-VyLibra | NORGESTIMATE AND ETHINYL ESTRADIOL | Afaxys Pharma, LLC | f59acc3e-21d9-4fa3-ad52-d77225739e1a | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 687424 |
| norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | AvKARE | a3cfd79e-a344-1dfc-e053-2995a90a1ab7 | 2024-01-10 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Mili | NORGESTIMATE AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | 22cfceff-0429-466f-a015-33cfdc505d44 | 2024-01-02 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Xiromed, LLC. | 1ba8a8ab-eb09-0807-47d4-6b4055d10d91 | 2023-08-01 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6ae97238-28cf-4bc9-a4ba-1e2bf4e3c600 | 2023-03-28 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Nymyo | NORGESTIMATE AND ETHINYL ESTRADIOL | Mayne Pharma Inc. | b13800f2-618f-468d-b8a5-2fc00595db61 | 2022-12-08 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Proficient Rx LP | 4a159dcd-8af4-4e59-8f46-7b0fe5c22807 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri-Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Proficient Rx LP | c1fc22e5-e02d-4dda-a9ac-c592e922c467 | 2020-01-01 | Boxed warning, Warnings, Adverse reactions | 687424 |
| Tri Femynor | NORGESTIMATE AND ETHINYL ESTRADIOL | Amneal Pharmaceuticals NY LLC | 46bbdf70-2b80-4359-a19b-d94ff99eac98 | 2016-08-30 | Boxed warning, Warnings, Adverse reactions | 687424 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6560d15f-6ce9-4f0e-9b59-043dec35ddd9 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 104 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20240521 |
| 6560d15f-6ce9-4f0e-9b59-043dec35ddd9 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 104 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20240521 |
| 8b247e46-203e-4f5b-b5a7-cbd57341c735 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 17 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20260206 |
| 8b247e46-203e-4f5b-b5a7-cbd57341c735 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 17 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20260206 |
| 843cbef6-cbfb-4a44-bb80-22930753e4c0 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 17 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250312 |
| 843cbef6-cbfb-4a44-bb80-22930753e4c0 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 17 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20250312 |
| 22cfceff-0429-466f-a015-33cfdc505d44 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 13 | These highlights do not include all the information needed to use TRI-MILI safely and effectively. See full prescribing information for TRI-MILI. Tri-Mili ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240102 |
| 22cfceff-0429-466f-a015-33cfdc505d44 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 13 | These highlights do not include all the information needed to use TRI-MILI safely and effectively. See full prescribing information for TRI-MILI. Tri-Mili ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240102 |
| b71a2b34-95bf-4430-83a0-1a4d1218ea3c | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 11 | These highlights do not include all the information needed to use Tri-Linyah safely and effectively. See full prescribing information for Tri-Linyah. Tri-Linyah (norgestimate/ethinyl estradiol) tablets, for oral use. Initial U.S. Approval: 1989 | 20251205 |
| b71a2b34-95bf-4430-83a0-1a4d1218ea3c | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use Tri-Linyah safely and effectively. See full prescribing information for Tri-Linyah. Tri-Linyah (norgestimate/ethinyl estradiol) tablets, for oral use. Initial U.S. Approval: 1989 | 20251205 |
| f59acc3e-21d9-4fa3-ad52-d77225739e1a | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 10 | These highlights do not include all the information needed to use Tri-VyLibra safely and effectively. See full prescribing information for Tri-VyLibra. Tri-VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240202 |
| f59acc3e-21d9-4fa3-ad52-d77225739e1a | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 10 | These highlights do not include all the information needed to use Tri-VyLibra safely and effectively. See full prescribing information for Tri-VyLibra. Tri-VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240202 |
| 1ba8a8ab-eb09-0807-47d4-6b4055d10d91 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 9 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20230801 |
| 1ba8a8ab-eb09-0807-47d4-6b4055d10d91 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 9 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20230801 |
| 6e8bec6f-17ba-4b37-ae6c-07657815f248 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets USP, for oral use Initial U.S. Approval: 1989 | 20251209 |
| 6e8bec6f-17ba-4b37-ae6c-07657815f248 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 8 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets USP, for oral use Initial U.S. Approval: 1989 | 20251209 |
| 1f8b9aad-f31f-4cda-861d-c08a977fc923 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 8 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20251001 |
| 1f8b9aad-f31f-4cda-861d-c08a977fc923 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use TRI-SPRINTEC ® safely and effectively. See full prescribing information for TRI-SPRINTEC ® . TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20251001 |
| 6ae97238-28cf-4bc9-a4ba-1e2bf4e3c600 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 8 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20230328 |
| 6ae97238-28cf-4bc9-a4ba-1e2bf4e3c600 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 8 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20230328 |
| 46bbdf70-2b80-4359-a19b-d94ff99eac98 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 6 | These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20160830 |
| 46bbdf70-2b80-4359-a19b-d94ff99eac98 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 6 | These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20160830 |
| b936a6fb-27ed-44de-9199-8c656bcd366e | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 5 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets USP, for oral use Initial U.S. Approval: 1989 | 20240423 |
| b936a6fb-27ed-44de-9199-8c656bcd366e | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 5 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets USP, for oral use Initial U.S. Approval: 1989 | 20240423 |
| 4a159dcd-8af4-4e59-8f46-7b0fe5c22807 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 4 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20220401 |
| 4a159dcd-8af4-4e59-8f46-7b0fe5c22807 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 4 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20220401 |
| f7f7c073-48e0-4065-970b-8103d76b6eb0 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20260127 |
| f7f7c073-48e0-4065-970b-8103d76b6eb0 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20260127 |
| a3cfd79e-a344-1dfc-e053-2995a90a1ab7 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 3 | Norgestimate and Ethinyl Estradiol Tablets, USP These highlights do not include all the information needed to use Norgestimate and Ethinyl Estradiol Tablets, USP safely and effectively. See full prescribing information for Norgestimate and Ethinyl Estradiol Tablets, USP. Initial U.S. Approval: 1989 | 20240110 |
| a3cfd79e-a344-1dfc-e053-2995a90a1ab7 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 3 | Norgestimate and Ethinyl Estradiol Tablets, USP These highlights do not include all the information needed to use Norgestimate and Ethinyl Estradiol Tablets, USP safely and effectively. See full prescribing information for Norgestimate and Ethinyl Estradiol Tablets, USP. Initial U.S. Approval: 1989 | 20240110 |
| 02e5c9a1-6002-499e-abe2-8473a5854178 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20231004 |
| 02e5c9a1-6002-499e-abe2-8473a5854178 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20231004 |
| 8a4aa52f-fe7b-4814-9488-009fddfbfbb1 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 3 | These highlights do not include all the information needed to use Tri-VyLibra safely and effectively. See full prescribing information for Tri-VyLibra. Tri-VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20230607 |
| 8a4aa52f-fe7b-4814-9488-009fddfbfbb1 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 3 | These highlights do not include all the information needed to use Tri-VyLibra safely and effectively. See full prescribing information for Tri-VyLibra. Tri-VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20230607 |
| c1fc22e5-e02d-4dda-a9ac-c592e922c467 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 3 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets USP) | 20200101 |
| c1fc22e5-e02d-4dda-a9ac-c592e922c467 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 3 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets USP) | 20200101 |
| b13800f2-618f-468d-b8a5-2fc00595db61 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use Tri-Nymyo safely and effectively. See full prescribing information forTri-Nymyo. Tri-Nymyo (norgestimate/ethinyl estradiol tablets) for oral use. Initial U.S. Approval: 1989 | 20221208 |
| b13800f2-618f-468d-b8a5-2fc00595db61 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use Tri-Nymyo safely and effectively. See full prescribing information forTri-Nymyo. Tri-Nymyo (norgestimate/ethinyl estradiol tablets) for oral use. Initial U.S. Approval: 1989 | 20221208 |
| 0d754d53-2a8b-40c8-9008-64390cd72dd0 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20200118 |
| 0d754d53-2a8b-40c8-9008-64390cd72dd0 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20200118 |
| 643b9e90-2bfc-411d-89cc-344add0e4205 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use MonoNessa or TriNessa safely and effectively. See full prescribing information for MonoNessa and TriNessa. MonoNessa ® and TriNessa ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20190412 |
| 643b9e90-2bfc-411d-89cc-344add0e4205 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use MonoNessa or TriNessa safely and effectively. See full prescribing information for MonoNessa and TriNessa. MonoNessa ® and TriNessa ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20190412 |
| c7de193c-d730-4f63-aa23-178b5f400967 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 2 | ORTHO TRI-CYCLEN ® TABLETS ORTHO-CYCLEN ® TABLETS (norgestimate/ethinyl estradiol) | 20120227 |
| c7de193c-d730-4f63-aa23-178b5f400967 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 2 | ORTHO TRI-CYCLEN ® TABLETS ORTHO-CYCLEN ® TABLETS (norgestimate/ethinyl estradiol) | 20120227 |
| d9744d1c-032d-45a7-95aa-382831107a1d | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use Tri-Sprintec safely and effectively. See full prescribing information for Tri-Sprintec. TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20160129 |
| d9744d1c-032d-45a7-95aa-382831107a1d | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use Tri-Sprintec safely and effectively. See full prescribing information for Tri-Sprintec. TRI-SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20160129 |
| 9599335c-4a8f-435d-b96c-27d5e5e34c39 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 1 | TriNessa ® Tablets (norgestimate and ethinyl estradiol) | 20120523 |
| 9599335c-4a8f-435d-b96c-27d5e5e34c39 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 1 | TriNessa ® Tablets (norgestimate and ethinyl estradiol) | 20120523 |
| faafb8ce-6955-4de4-8b93-ccc662123b5e | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 1 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only | 20120419 |
| faafb8ce-6955-4de4-8b93-ccc662123b5e | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 1 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only | 20120419 |
| 69e66f08-be0b-4120-9a30-333b34ad3507 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 1 | TriNessa ® Tablets (norgestimate and ethinyl estradiol) | 20110913 |
| 69e66f08-be0b-4120-9a30-333b34ad3507 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 1 | TriNessa ® Tablets (norgestimate and ethinyl estradiol) | 20110913 |
| 7fd4976d-720c-40ee-8723-a703645d4ff0 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 1 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only | 20110906 |
| 7fd4976d-720c-40ee-8723-a703645d4ff0 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 1 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only | 20110906 |
| cbcb4427-7a99-467c-915f-a8b4c90e2832 | norgestimate 0.215 MG / ethinyl estradiol 0.035 MG Oral Tablet | PSN | 1 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only | 20110803 |
| cbcb4427-7a99-467c-915f-a8b4c90e2832 | ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet | SCD | 1 | Tri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only | 20110803 |